EUDA Health (NASDAQ:EUDA – Get Free Report) and SOPHiA GENETICS (NASDAQ:SOPH – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, analyst recommendations, risk, dividends and valuation.
Earnings and Valuation
This table compares EUDA Health and SOPHiA GENETICS”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| EUDA Health | $4.01 million | 19.09 | -$15.36 million | N/A | N/A |
| SOPHiA GENETICS | $69.69 million | 3.36 | -$62.49 million | ($0.44) | -7.86 |
Analyst Ratings
This is a summary of current ratings and target prices for EUDA Health and SOPHiA GENETICS, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| EUDA Health | 0 | 0 | 0 | 1 | 4.00 |
| SOPHiA GENETICS | 0 | 0 | 1 | 0 | 3.00 |
SOPHiA GENETICS has a consensus target price of $8.00, suggesting a potential upside of 131.21%. Given SOPHiA GENETICS’s higher possible upside, analysts plainly believe SOPHiA GENETICS is more favorable than EUDA Health.
Profitability
This table compares EUDA Health and SOPHiA GENETICS’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| EUDA Health | N/A | N/A | N/A |
| SOPHiA GENETICS | -40.99% | -30.69% | -17.39% |
Volatility & Risk
EUDA Health has a beta of -0.06, meaning that its stock price is 106% less volatile than the S&P 500. Comparatively, SOPHiA GENETICS has a beta of 1, meaning that its stock price has a similar volatility profile to the S&P 500.
Insider & Institutional Ownership
4.4% of EUDA Health shares are owned by institutional investors. Comparatively, 31.6% of SOPHiA GENETICS shares are owned by institutional investors. 4.9% of SOPHiA GENETICS shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Summary
EUDA Health beats SOPHiA GENETICS on 7 of the 13 factors compared between the two stocks.
About EUDA Health
EUDA Health Holdings Limited operates as a healthcare specialty company. The company operates through two segments, Medical Services and Property Management Services. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses. The company is also involved in the property management that services shopping malls, business office building, or residential apartments. EUDA Health Holdings Limited is headquartered in Singapore.
About SOPHiA GENETICS
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.
Receive News & Ratings for EUDA Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EUDA Health and related companies with MarketBeat.com's FREE daily email newsletter.
